posted June 23, 2022 03:39 am by cleareye
(151)
Q4 is out. Financial Highlights Delivered total revenue of $20.3 million in fiscal Q4 2022, an increase of 15% compared to fiscal Q4 2021 and, as expected, a decrease of 5% compared to fiscal
...read more
posted March 01, 2022 07:35 am by Betteryear2
(3281)
Medexus has acquired exclusive rights to commercialize Gleolan in the United States, complementing Medexus’s existing rights to Gleolan in Canada Gleolan is an optical imaging agent currently
...read more
posted January 11, 2022 12:08 pm by GoldenArm
(340)
Not sure how this will effect MDP but it is definitely is a good move for Pine. "Most recently, Mr. Pine was a Senior Vice President of Business Development and Strategy at Medexus
...read more
posted December 30, 2021 09:53 am by GoldenArm
(340)
Excellent news on the Type A meeting but we are still 2 to 6 months out. Hoping to hear excellent numbers in the next financials. I've moved my buy in up by 4 months. I'll be looking to get
...read more
posted November 18, 2021 03:58 pm by russter
(34)
Lets hope the type A's have a productive meeting and clear way forward. So we can get back to where it should be trading. I was grateful for the dip so I could av dn. Thanks all! Russ
rate and reply
posted November 09, 2021 03:49 pm by GoldenArm
(340)
I maybe back in 6 months or so.
rate and reply
posted November 03, 2021 03:40 pm by GoldenArm
(340)
up 6.3%. I'm wondering about the Type A meeting. If it is just about the numbers then approval could be 60 to 90+ away, depending on how fast they can present the data. I'm not sure about this
...read more
posted November 03, 2021 09:08 am by GoldenArm
(340)
I got this from a Yahoo Finance. Basically good new but it takes time. Type A Meetings The FDA and the applicants of regulatory filings interact with each other during the review period regarding
...read more
posted November 01, 2021 02:05 pm by GoldenArm
(340)
Good news. If all goes well this will be an easy double in my opinion.
rate and reply
posted November 01, 2021 09:44 am by Betteryear2
(3281)
TORONTO and CHICAGO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) today announced that the U.S. Food
...read more
posted October 26, 2021 08:34 am by Betteryear2
(3281)
TORONTO and CHICAGO and MONTREAL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d’Entremont, Chief
...read more
posted October 14, 2021 04:40 pm by cleareye
(151)
This seems to be the season for large increases without news. Compression triangles are being tripped for large increases. Pricking thumb? Pricking balloon? cleareye.
rate and reply
posted October 14, 2021 01:53 pm by GoldenArm
(340)
Good move to the upside however volume, better, is still small so maybe there is news. If this stays on an upward trend then yes something good is coming, in my opion which is not expert opinion.
rate and reply
posted September 23, 2021 05:06 pm by OPFunds
(17)
https://m.youtube.com/watch?v=dAxo7aUJkPg&feature=youtu.be
rate and reply
posted September 23, 2021 08:50 am by GoldenArm
(340)
Medexus Announces Expanded Availability of Trecondyv® (treosulfan) in Canada If you read the article you get the gist that Doctors are very happy with the results they get from the drug. FDA is
...read more
posted September 13, 2021 11:51 am by GoldenArm
(340)
Event hough I'm down on this stock, buying on the dips has made me money. I'm trading this right now trying to reduce the pain as much as I can.
rate and reply
posted September 10, 2021 02:10 pm by GoldenArm
(340)
The FDA wanted the numbers on Treos crunched to their standards and that is a medac problem not MDP. However it is a waiting game for those numbers to come in and this stock to go beyond $8 to $10
...read more
posted September 07, 2021 09:39 am by GoldenArm
(340)
I apologize to the board this was meant for GRN not MDP
rate and reply